GlaxoSmithKline News and Research

RSS

Actions taken on HPV vaccine proposals in Alabama, Louisiana, Utah, Washington

The following highlights recent news of state actions on human papillomavirus vaccine proposals. Merck's HPV vaccine Gardasil and GlaxoSmithKline's HPV vaccine Cervarix in clinical trials have been shown to be 100% effective in preventing infection with HPV strains 16 and 18, which together cause about 70% of cervical cancer cases.

13 Feb 2007

Approval of orlistat capsules over-the-counter

The U.S. Food and Drug Administration (FDA) today approved orlistat capsules as an over-the-counter (OTC) weight loss aid for overweight adults.

7 Feb 2007

Ranbaxy and GlaxoSmithKline form alliance

Ranbaxy Laboratories announced today that the Company and GlaxoSmithKline have signed a new, multiyear R&D agreement that modifies and expands the terms of their strategic alliance established in 2003 to provide Ranbaxy expanded drug-development responsibilities and further financial opportunities.

6 Feb 2007

Many low-income Medicare beneficiaries receive no help from PAPs

Many low-income Medicare beneficiaries enrolled in the prescription drug benefit receive no help from patient assistance programs operated by pharmaceutical companies, according to advocacy groups, USA Today reports.

6 Feb 2007

GlaxoSmithKline issues update on US patent litigation regarding Valtrex

GlaxoSmithKline has issued an update on US patent litigation regarding Valtrex (valacyclovir), an antiviral drug used for the treatment and suppression of genital herpes, herpes zoster (shingles), and cold sores.

5 Feb 2007

GlaxoSmithKline's new influenza vaccine accepted for review in Europe

GlaxoSmithKline has announced that its new generation H5N1 split antigen pre-pandemic influenza vaccine has been accepted for review by the Committee for Medicinal Products for Human Use (CHMP) in Europe.

29 Jan 2007

CogState issued US patent

CogState has announced that it has been issued a patent from the Unites States Patent & Trade Mark Office (US patent no. 7,163,513) for the key technology platform used in its computer-based tests of brain function.

16 Jan 2007

Race to accelerate tuberculosis drug development

Each year, tuberculosis kills nearly two million people while an estimated nine million develop the disease -- with the hardest-hit areas in AIDS-afflicted developing nations.

14 Jan 2007

How to save a million lives a year

A promise of $200 million from some of the world's richest nations to fight diseases in poor countries will save more than a million children's lives a year.

1 Dec 2006

US orders more bird flu vaccine for the stockpile

The U.S. government has ordered enough vaccine to protect another 2.7 million people against bird flu.

22 Nov 2006

HHS purchases more vaccines for an influenza pandemic

HHS has announced the purchase of additional vaccine that could be used in the event of a potential influenza pandemic.

20 Nov 2006

GSK about to sign another big bird flu deal

Europe's largest drug maker GlaxoSmithKline is said to be about to sign another deal to provide tens of millions of doses of it's experimental H5N1 vaccine for humans.

30 Oct 2006

High rates of pertussis found in States with easy immunization exemptions

States that easily permit parents to opt out of vaccinating their children for nonmedical reasons are at increased risk of pertussis (whooping cough), according to a new study from researchers with the Johns Hopkins Bloomberg School of Public Health, the University of Florida and the Centers for Disease Control and Prevention (CDC).

10 Oct 2006

A pill a day gives renewed hope for breast cancer victims

A new breast cancer 'wonder drug' could be available to British women within a matter of months.

9 Oct 2006

FDA approves FluLaval

The U.S. Food and Drug Administration (FDA) today approved FluLaval, an influenza vaccine to immunize people 18 years of age and older against the disease caused by strains of influenza virus judged likely to cause seasonal flu in the Northern Hemisphere in 2006-2007.

5 Oct 2006